That is what FeyeCon aims for. Using CO₂ based processes for drug isolation, purification and formulation we create completely new and improved pharmaceutical and biomedical products. Our CO₂ technology is mild and leaves no residual solvents. It offers a very versatile and tunable process.
Our mild and versatile CO₂ technology achieves:
Our particles are characterized by:
At our laboratory in Weesp, The Netherlands, we have cGMP facilities that operate supercritical CO₂ equipment available to external parties. Our facilities – including a certified class D cleanroom – allow for the cGMP production of clinical batches and contract manufacturing.
Read more about our Pharmaceutical and Biomedical Technology